该项收购完成后,Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造,到独立分析、微生物测验以及固态科学等多项服务,同时将Avista的4个制药站点纳入其生...查看全文
琬麟2015-02-07 09:21
$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文
$凯姆布雷克斯(CBM)$ UPLOAD [Cover] - SEC-generated letter Filed: 2017-12-21 AccNo: 0000000000-17-044598 Size: 133 KB 网页链接
$凯姆布雷克斯(CBM)$ UPLOAD [Cover] - SEC-generated letter Filed: 2018-01-05 AccNo: 0000000000-18-000473 Size: 40 KB 网页链接
$凯姆布雷克斯(CBM)$ UPLOAD [Cover] - SEC-generated letter Filed: 2017-12-21 AccNo: 0000000000-17-044598 Size: 133 KB 网页链接
$凯姆布雷克斯(CBM)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-07 AccNo: 0001437749-17-018451 Size: 4 MB 网页链接
$凯姆布雷克斯(CBM)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-07 AccNo: 0001437749-17-018451 Size: 4 MB 网页链接
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2017-11-07 AccNo: 0001437749-17-018449 Size: 386 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2017-11-07 AccNo: 0001437749-17-018449 Size: 386 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2017-11-03 AccNo: 0001437749-17-018284 Size: 114 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2017-11-03 AccNo: 0001437749-17-018208 Size: 33 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial S...
$凯姆布雷克斯(CBM)$ 美东时间 2017-11-07 盘前 披露财报,预期EPS 0.47 网页链接